ASTRAZENECA PLC (AZN)
Clinical trial NCT07069712 updates: 1. completion date: 2028-09-06 → 2029-07-16 2. primary completion date: 2027-01-28 → 2027-11-03
Clinical trial NCT07069712 updates: 1. completion date: 2028-09-06 → 2029-07-16 2. primary completion date: 2027-01-28 → 2027-11-03
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical